Skip to content

Clinical trials

Phase 3 Hypersensitivity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 3 Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20062
20071
20083
20101
20121
20151
20161
20174
20184
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergopharma GmbH & Co. KG6
Aimmune Therapeutics, Inc.5
ALK-Abelló A/S4
Celgene2
Pfizer2
Stallergenes Greer2
Artu Biologicals1
AstraZeneca1
DBV Technologies1
HAL Allergy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity27
Peanut Hypersensitivity6
Immune System Diseases4
Asthma3
Hypersensitivity, Immediate3
Bronchial Diseases2
Dermatitis2
Dermatitis, Atopic2
Dust Mite Allergy2
Eczema2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.